文献速递产科母胎医学

产前糖皮质激素对早产双胎的疗效:EPIPAGE-2队列研究

Efficacy of antenatal corticosteroids in preterm twins: the EPIPAGE-2 cohort study.
PubMed 文献 · BJOG · 2017-12-14

EPIPAGE-2是一项法国全国性观察性多中心前瞻性队列研究,纳入2011年3月至12月出生的750名24至31周双胎新生儿,分析产前糖皮质激素对严重支气管肺发育不良、脑室周围白质软化或III/IV级脑室内出血、院内死亡及复合严重结局的影响。与未使用ACS相比,单疗程且给药至分娩间隔≤7天与脑室周围白质软化或III/IV级脑室内出血率降低(aOR 0.2;95%CI 0.1-0.5)、院内死亡率降低(0.3;0.1-0.6)及复合指标降低(0.1;0.1-0.3)显著相关,而间隔>7天未显著降低院内死亡率(0.7;0.3-1.8);重复疗程与单完整疗程在获益或风险方面无显著差异。

要点

  • 早产双胎中,单完整疗程ACS与严重神经结局改善相关。
  • 仅当ACS给药至分娩间隔≤7天时,院内死亡率降低。
  • 重复疗程与单完整疗程在获益或风险上无显著差异。

核心结论

  • 在早产双胎中,单完整疗程产前糖皮质激素与严重神经结局改善相关,而院内死亡率降低仅见于ACS给药至分娩间隔≤7天时。

研究设计与样本

  • EPIPAGE-2为法国全国性观察性多中心前瞻性队列研究,纳入2011年3月至12月出生、胎龄22至34周的新生儿。
  • 分析样本为750名胎龄24至31周的雙胎新生儿。

主要发现

  • 与未使用ACS相比,单疗程ACS且给药至分娩间隔≤7天与脑室周围白质软化或III/IV级脑室内出血率降低显著相关(aOR 0.2;95%CI 0.1-0.5)。
  • 与未使用ACS相比,单疗程ACS且给药至分娩间隔≤7天与院内死亡率降低显著相关(aOR 0.3;95%CI 0.1-0.6)。
  • 与未使用ACS相比,单疗程ACS且给药至分娩间隔≤7天与复合严重结局指标降低显著相关(aOR 0.1;95%CI 0.1-0.3)。
  • 与未使用ACS相比,单疗程ACS且给药至分娩间隔>7天未显著降低院内死亡率(aOR 0.7;95%CI 0.3-1.8)。
  • 重复疗程与单完整疗程在获益或风险方面无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the efficacy of antenatal corticosteroid (ACS) therapy on short-term neonatal outcomes in preterm twins, and further document the influence of the ACS-to-delivery interval. DESIGN: EPIPAGE-2 is a nationwide observational multicentre prospective cohort study of neonates born between 22 and 34 completed weeks of gestation. SETTING: All French maternity units, except in a single administrative region, between March and December 2011. POPULATION: A total of 750 twin neonates born between 24 and 31 weeks of gestation. METHODS: Exposure to ACSs was examined in four groups: single complete course, with an ACS administration-to-delivery interval of ≤7 days; single complete course, with an ACS-to-delivery interval of >7 days; repeated courses; or no ACS treatment. MAIN OUTCOME MEASURES: Neonatal outcomes analysed were severe bronchopulmonary dysplasia, periventricular leukomalacia or intraventricular haemorrhage grade III/IV, in-hospital mortality, and a composite indicator of severe outcomes. RESULTS: Compared with no ACSs, in multivariable analysis, a single course of ACSs with an administration-to-delivery interval of ≤7 days was significantly associated with a reduced rate of periventricular leukomalacia or intraventricular haemorrhage grade III/IV (aOR 0.2; CI 95% 0.1-0.5), in-hospital mortality (0.3; 0.1-0.6), and the composite indicator (0.1; 0.1-0.3), whereas a single course of ACDs with an administration-to-delivery interval of >7 days did not significantly reduce the frequency of in-hospital mortality (0.7; 0.3-1.8). No significant differences in terms of benefit or risk were found when comparing repeated courses with a single complete course. CONCLUSION: In preterm twins, a single complete course of antenatal corticosteroids was associated with an improvement of severe neurological outcome, whereas reduced in-hospital mortality was seen only when the ACS-to-delivery interval was ≤7 days. TWEETABLE ABSTRACT: A single complete course of antenatal steroids reduced severe neurological morbidity in preterm twins (24-31 weeks).

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Palas D, Ehlinger V, Alberge C, et al. Efficacy of antenatal corticosteroids in preterm twins: the EPIPAGE-2 cohort study. BJOG. 2017. PMID: 29119673. doi:10.1111/1471-0528.15014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。